Giuseppe Rosano

Giuseppe Rosano

Consultant Cardiologist and Professor of Cardiology (Hon)

St George’s University Medical School of London, UK

  • LinkedIn
  • Radcliffe

Biography

Prof Rosano is a consultant cardiologist and honorary professor of cardiology at St George’s University Medical School in London, and scientific director of the Nutramed program at the IRCCS San Raffaele, in Rome, and professor of pharmacology at the University of Catanzaro.

He currently serves as an expert in cardiovascular medicine for the European Assessment Office of the Italian Drug Agency and is a core member of the Cardiovascular Working Party of the European Medicines Agency.

Prof Rosano is a board member of the Heart Failure Association (HFA), and is chairman of the HFA's education committee and the HFA Study Group on Diabetes and Hypertension. He serves as deputy editor-in-chief of Cardiac Failure Review.

Articles

Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(2):68–9.

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

Giuseppe Rosano, Ilaria Spoletini, Cristiana Vitale,

Published:

Citation: Cardiac Failure Review 2019;5(3):130–2.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(3):128–9.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2019;5(1):4.

Erratum to: Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(1):62.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(2):68-9.

Metabolic Modulation of Cardiac Metabolism in Heart Failure

Giuseppe Rosano, Cristiana Vitale,

Citation: Cardiac Failure Review 2018;4(2):99–103.

Frailty in Heart Failure: Implications for Management

Cristiana Vitale, Ilaria Spoletini, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(2):104–6.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(1):4–5

Pharmacological Interventions Effective in Improving Exercise Capacity in Heart Failure

Cristiana Vitale, Ilaria Spoletini, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(1):25–7.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(2):77–8.

Heart Failure in Patients with Diabetes Mellitus

Giuseppe Rosano, Cristiana Vitale, Petar M Seferovic,

Citation: Cardiac Failure Review 2017;3(1):52–5.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(1):5–6

Practical Applications for Single Pill Combinations in the Cardiovascular Continuum

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz,

Citation: Cardiac Failure Review 2017;3(1):40–5.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(1):6-7.

The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines

Ivan Milinkovic, Giuseppe Rosano, Yury Lopatin,

Citation: Cardiac Failure Review, 2016;2(2):123–9

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(2):78.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(2):62-3.

Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(1):6-7.

Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Giuseppe Rosano, David Quek, Felipe Martínez,

Published:

Citation: Cardiac Failure Review 2020;6:e31.

Keywords

Hypertension, Exercise Physiology, Insulin Resistance, Exercise Testing, Atrial Fibrillation, Blood Pressure, Exercise Intervention, Cardiology, Interventional Cardiology, Diabetes Mellitus, Metabolic Syndrome, Vascular Diseases, Endothelial Dysfunction, Endothelial Function, Pharmaceutical Care, Regulatory Affairs, Exercise Therapy, Pharma Sciences